Reata Pharmaceuticals (RETA) PT Raised to $51 at Citi on Potential Omav Approval Oct 14, 2022 06:18AM
Reata Pharmaceuticals Announces Participation in the Citi 17th Annual BioPharma Conference Sep 6, 2022 04:51PM
Reata Pharma (RETA) defended at Citi Mar 28, 2022 01:28PM
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Nov 18, 2019 11:15AM
Reata Pharma (RETA) Prices 2.4M Class A Share Upsized Common Offering at $183/Sh Nov 14, 2019 05:58AM


Nov 13, 2019 07:15PM Reata Pharmaceuticals, Inc. Announces Pricing of Upsized Class A Common Stock Public Offering
Nov 12, 2019 04:03PM Reata Pharma (RETA) Announces 2M Share Proposed Public Offering of Class A Common Stock
Nov 12, 2019 04:01PM Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock
Oct 15, 2019 09:22AM Pre-Open 10/15 (RETA) (AXAS) (UNH) Higher (PAGS) (GS) (BLMN) Lower (more...)
Oct 15, 2019 07:59AM UPDATE: Reata Pharmaceuticals (RETA) PT Raised to 'Street High' $241 at Citi as Omav Upside Realized
Aug 9, 2019 06:17AM Reata Pharmaceuticals (RETA) PT Raised to $194 at Citi
May 31, 2019 07:38AM Reata Pharmaceuticals (RETA) PT Raised to $190 at Citi
Mar 20, 2019 10:03AM Reata Pharma (RETA): KOL Positive on Bardoxolone's Potential in CKD - Citi
Jul 25, 2018 06:48AM Reata Pharmaceuticals (RETA) PT Raised to $185 at Citi, Added to US Focus List
Jul 23, 2018 01:12PM Reata Pharmaceuticals (RETA) PT Raised to $95 at Citi
May 10, 2018 06:39AM Reata Pharmaceuticals (RETA) PT Lowered to $76 at Citi
Aug 23, 2017 08:50AM Reata Pharmaceuticals (RETA) PT Lowered to $78 at Citi
Jul 25, 2017 09:15AM Reata Pharma (RETA): 123% PT Increase - Citi
May 9, 2017 06:32AM Reata Pharmaceuticals (RETA) PT Raised to $39 at Citi
Dec 6, 2016 06:09AM Reata Pharma (RETA) Files Common Stock Shelf
Dec 6, 2016 06:00AM Reata Pharmaceuticals, Inc. Announces Filing of Registration Statement for Proposed Public Offering
Jun 1, 2016 03:29PM Reata Pharmaceuticals (RETA) Closes 6.33M Common Stock IPO; Includes Full Underwriter Overallotment
Jun 1, 2016 02:49PM Reata Pharmaceuticals, Inc. Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares of Class A Common Stock
May 26, 2016 10:39AM Reata Pharmaceuticals (RETA) IPO Opens Flat
May 26, 2016 06:32AM Reata Pharma (RETA) Prices 5.5M Class A Common Stock IPO at $11/Share
May 25, 2016 11:19PM Reata Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
Jan 4, 2016 03:49PM Reata Pharmaceuticals (RETA) Files $80M Common Stock IPO